title: Hepatitis C and liver transplantation.
abstract: Cirrhosis due to chronic hepatitis C is the leading indication for liver transplantation in Europe, United States and Japan. Reinfection after liver transplantation is universal and chronic liver disease develops in at least 70% of patients at 3 years, with an accelerated course compared to the nontransplant setting. These facts underscore the need for a better understanding of hepatitis C infection and the various treatment modalities. This paper attempts a brief review of the scope of the disease, as well as the different treatment modalities, with special emphasis given to orthotopic liver transplantation.
authors.affiliation: Surgical Department of Transplantation, Aristotle University, Hippokratio General Hospital, Thessaloniki, Greece. tsoulfasg@msn.com
authors.forename: G
authors.initials: G
authors.lastname: Tsoulfas
authors.forename: I
authors.initials: I
authors.lastname: Goulis
authors.forename: D
authors.initials: D
authors.lastname: Giakoustidis
authors.forename: E
authors.initials: E
authors.lastname: Akriviadis
authors.forename: P
authors.initials: P
authors.lastname: Agorastou
authors.forename: G
authors.initials: G
authors.lastname: Imvrios
authors.forename: V
authors.initials: V
authors.lastname: Papanikolaou